Creating better breakthrough science
We help teams elucidate and better understand disease biology, improve patient stratification through molecular and phenotypical insights and the leverage of patient clinical insights to optimize modality choice and identify novel targets, biomarkers and drug candidates.
Increasing the probability of success
We work with clients to reduce risk, scale the probability of scientific regulatory success and reimbursement success through data, AI, analytics and technology-driven platforms.
Transforming R&D organizations
We help organizations become more agile, overcome inertia, break silos and optimize the right talent pool to promote disruptive innovation, foster organization-wide transformation and drive nonlinear drug development.
Uncover protein functions and disease hypotheses with ZS Revelen
Unlocking a wealth of insights
We accelerate drug discovery by uncovering novel aspects of disease biology to identify new targets. We help identify biomarkers and design and execute experiments, while applying in silico methods to deliver therapies to market faster.
Data and knowledge management
We help clients advance research by using data and AI platforms for in silico science. We leverage ML, customized bioinformatics analyses and multiomics platforms to make research data accessible and actionable.
Research strategy and transformation
We plan and design digital transformations of research and early development—including scientific strategy, benchmarking and more—while preparing the existing organization for the change.
We leverage our expertise in population analytics and multiomics analysis of disease biology to deliver the right medicine to the right patient at the right time.
From streaming analytics and AI to business intelligence, Databricks provides a modern lakehouse architecture that unifies data engineering, data science, ML and analytics within a single collaborative platform.
This partnership enables life sciences companies to scale their research environments to improve patient outcomes. ZS offers a range of services related to Seqera Labs’ technologies that help clients address a broad set of end-to-end challenges.
This partnership aims to help innovate drug research and propel precision medicine by combining ZS’s expertise in biomedical research services and data science with Velsera’s technology platform.
ZS and ONTOFORCE support clients in optimizing their research and development operations. We leverage use cases, omics data analysis, biomarker selection and more to offer an end-to-end service for early drug research and development.